Drug
taurolidine
taurolidine is a pharmaceutical drug with 6 clinical trials. Historical success rate of 80.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_4
1
17%
Ph phase_1
2
33%
Ph phase_3
1
17%
Ph not_applicable
1
17%
Phase Distribution
2
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Terminated(1)
Other(1)
Detailed Status
Completed4
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 12 (40.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)
Trials by Status
completed467%
terminated117%
unknown117%
Recent Activity
0 active trials
Showing 5 of 6
completed
Taurolidine Containing Antimicrobial CIED Wash to Prevent Infection
NCT05576194
unknownphase_4
Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children
NCT02515201
completedphase_1
Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00021034
completedphase_1
Taurolidine in Treating Patients With Recurrent or Progressive Glioma
NCT00022360
terminatednot_applicable
Effect of Taurolidin on Prevention of Bloodstream Infection
NCT00545831
Clinical Trials (6)
Showing 6 of 6 trials
NCT05576194
Taurolidine Containing Antimicrobial CIED Wash to Prevent Infection
NCT02515201Phase 4
Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children
NCT00021034Phase 1
Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00022360Phase 1
Taurolidine in Treating Patients With Recurrent or Progressive Glioma
NCT00545831Not Applicable
Effect of Taurolidin on Prevention of Bloodstream Infection
NCT00321165Phase 3
The AOT (Acridine Orange and Taurolidine) Trial
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6